Literature DB >> 16492093

Personality traits and the development of nicotine, alcohol, and illicit drug disorders: prospective links from adolescence to young adulthood.

Irene J Elkins1, Serena M King, Matt McGue, William G Iacono.   

Abstract

The personality traits constraint (CN) and negative emotionality (NE) have been more (CN) or less (NE) consistently associated with alcoholism. The authors examined the association of personality at age 17 with timing of onset and with prospective prediction of nicotine, alcohol, and illicit drug disorders 3 years later in a twin sample (569 females; 432 males). Earlier onset of alcohol and drug disorders (by age 17) was related to significantly lower CN compared with later onsets (by age 20); high NE was related to either onset. NE, as well as CN, uniquely predicted new onsets of all 3 types of substance use disorders by follow-up, with preexisting substance disorders taken into account. Personality traits confer generalized risk for developing any substance disorder, though some traits are more strongly linked with some substance disorders than with others. 2006 APA, all rights reserved

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492093     DOI: 10.1037/0021-843X.115.1.26

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  83 in total

1.  Impulsivity is an independent predictor of 15-year mortality risk among individuals seeking help for alcohol-related problems.

Authors:  Daniel M Blonigen; Christine Timko; Bernice S Moos; Rudolf H Moos
Journal:  Alcohol Clin Exp Res       Date:  2011-06-01       Impact factor: 3.455

2.  Is the continuity of externalizing psychopathology the same in adolescents and middle-aged adults? A test of the externalizing spectrum's developmental coherence.

Authors:  Scott I Vrieze; Greg Perlman; Robert F Krueger; William G Iacono
Journal:  J Abnorm Child Psychol       Date:  2012-04

3.  Alcoholics Anonymous attendance, decreases in impulsivity and drinking and psychosocial outcomes over 16 years: moderated-mediation from a developmental perspective.

Authors:  Daniel M Blonigen; Christine Timko; John W Finney; Bernice S Moos; Rudolf H Moos
Journal:  Addiction       Date:  2011-09-21       Impact factor: 6.526

4.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

5.  A longitudinal study of the reciprocal relationship between ever smoking and urgency in early adolescence.

Authors:  Jessica L Burris; Elizabeth Riley; Gabriella E Puleo; Gregory T Smith
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

6.  Conjoint developmental trajectories of young adult substance use.

Authors:  Kristina M Jackson; Kenneth J Sher; John E Schulenberg
Journal:  Alcohol Clin Exp Res       Date:  2008-03-04       Impact factor: 3.455

7.  Risk factors in the relationship between gender and crack/cocaine.

Authors:  C W Lejuez; Marina A Bornovalova; Elizabeth K Reynolds; Stacey B Daughters; John J Curtin
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

8.  Alcoholics Anonymous and reduced impulsivity: a novel mechanism of change.

Authors:  Daniel M Blonigen; Christine Timko; Rudolf H Moos
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

9.  Examining risk and protective factors for alcohol use in lesbian, gay, bisexual, and transgender youth: a longitudinal multilevel analysis.

Authors:  Michael E Newcomb; Adrienne J Heinz; Brian Mustanski
Journal:  J Stud Alcohol Drugs       Date:  2012-09       Impact factor: 2.582

10.  The amphetamine response moderates the relationship between negative emotionality and alcohol use.

Authors:  Kenneth J D Allen; Frances H Gabbay
Journal:  Alcohol Clin Exp Res       Date:  2012-12-14       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.